Gene · 8321
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Analysis in Drosophila Reveals the Genetic Basis of Variation in Age-Specific Physical Performance and Response to ACE Inhibition. | Genes (Basel) | 2022 | 35052483 | PubTator, text mining | PubMed |
| Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd. | J Biol Chem | 2022 | 35032551 | PubTator, text mining | PubMed |
| Method for Estimating Temporal Gait Parameters Concerning Bilateral Lower Limbs of Healthy Subjects Using a Single In-Shoe Motion Sensor through a Gait Event Detection Approach. | Sensors (Basel) | 2022 | 35009893 | PubTator, text mining | PubMed |
| Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma. | Biomark Res | 2022 | 35000617 | PubTator, text mining | PubMed |
| Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. | Signal Transduct Target Ther | 2022 | 34980884 | PubTator, text mining | PubMed |
| Comprehensive analysis of the long noncoding RNA-associated competitive endogenous RNA network in the osteogenic differentiation of periodontal ligament stem cells. | BMC Genomics | 2022 | 34979896 | PubTator, text mining | PubMed |
| Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer. | J Cancer | 2022 | 34976185 | PubTator, text mining | PubMed |
| The role of microRNAs in glaucoma. | Exp Eye Res | 2022 | 34968473 | PubTator, text mining | PubMed |
| Identifying cancer pathway dysregulations using differential causal effects. | Bioinformatics | 2022 | 34927666 | PubTator, text mining | PubMed |
| Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression. | J Cell Biol | 2022 | 34889941 | PubTator, text mining | PubMed |
| Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality. | J Parkinsons Dis | 2022 | 34842194 | PubTator, text mining | PubMed |
| Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. | Nat Rev Microbiol | 2022 | 34837014 | PubTator, text mining | PubMed |
| Soluble ICAM-1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma. | Adv Sci (Weinh) | 2022 | 34813169 | PubTator, text mining | PubMed |
| Dvl2 facilitates the coordination of NF-κB and Wnt signaling to promote colitis-associated colorectal progression. | Cancer Sci | 2022 | 34807493 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. | Bone | 2022 | 34743040 | PubTator, text mining | PubMed |
| EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. | Oncogene | 2022 | 34718348 | PubTator, text mining | PubMed |
| Spatiotemporal map of key signaling factors during early penis development. | Dev Dyn | 2022 | 34697862 | PubTator, text mining | PubMed |
| A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models. | Mol Cancer Ther | 2022 | 34667113 | PubTator, text mining | PubMed |
| Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer. | Cancer Res | 2022 | 34625422 | PubTator, text mining | PubMed |
| Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure. | Int J Cancer | 2022 | 34569060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/papers?page=24